Wendy Young is a biotech executive with more than 30 years of experience in the discovery and development of new medicines for patients. She currently serves as a Board Member and Scientific Advisor at several biotech companies and is an Advisor at Google Ventures. Previously, Wendy was the Senior Vice President, Small Molecule Drug Discovery, at Genentech where she actively built and led the research & discovery organization. Under her leadership, more than 25 clinical candidates progressed into development. Additionally, Wendy led the BTK discovery program and is co-inventor of fenebrutinib, which is currently in Phase 3 trials for multiple sclerosis. Prior to joining Genentech, Wendy held leadership roles at Celera Genomics and Scios, a J&J company. Wendy earned her Ph.D. in chemistry from Princeton University under the guidance of E.C. Taylor and was a Postdoctoral Fellow in the laboratories of Samuel Danishefsky at Sloan-Kettering Cancer Center.
